Aarti Drugs Ltd.

Frost & Sullivan Names Intel Health Guide Home Health Device Product of the Year; Intel Recognized for Innovation in Health Care and the Advancement of Better Communications between Patients and their Care Teams.
M2 Presswire; 3/18/2009; 1018 words; ...1994-2009 M2 COMMUNICATIONS LTD RDATE:18032009 SAN FRANCISCO...clearance from the U.S. Food and Drug Administration (FDA) in July...amp; Sullivan Industry Analyst Aarti Shetty. "A powerful care management...others. ((M2 Communications Ltd disclaims all liability for information...

Frost & Sullivan: Trauma Fixation Device Manufacturers Use Innovative Strategies to Build Customer Loyalty.
Health & Beauty Close-Up; 7/8/2008; 914 words; ...Sullivan Industry Analyst Aarti Shetty. Antibiotic prophylaxis...availability of sophisticated drugs that improve bone density and...constant development of superior drugs for treatment of bone density...Distributed via M2 Communications Ltd - http://www.m2.com...

Development of a pMDI formulation containing budesonide.(Proceedings of the Symposium on Advances in Pulmonary and Nasal Drug Delivery, October 2007, Mumbai)(pressurised metered dose inhalers)(Clinical report)
Indian Journal of Pharmaceutical Sciences; 9/1/2007; 1374 words; ...budesonide (supplied by Aarti Healthcare Ltd, India) introduced into...evaluated with regard to drug stability upon storage...irreproducible dosing of the drug. The stable suspension...development of inhalation drug delivery systems. Pharmaceutical...

AARTI DRUGS CLARIFIES ON NEWS ITEM
The Hindustan Times; 6/15/2007; 315 words; ...item appearing in a leading daily titled "Aarti Ind, Aarti Drugs merger on cards", Aarti Drugs Ltd., has clarified to BSE that there is no...rumours of picking up of equity stake by any drug major in the Company, the Company deny the...

AARTI DRUGS ANNOUNCES OUTCOME OF BOARD MEETING
The Hindustan Times; 5/18/2007; 291 words; ...MUMBAI, India, May 18 -- The Bombay Stock Exchange Limited (BSE) made the following corporate announcement: Aarti Drugs Ltd., has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2007, has not recommended...